封面
市場調查報告書
商品編碼
2050653

血栓除去裝置市場:按產品類型、應用、最終用戶和地區分類

Thrombectomy Devices Market, By Product Type, By Application, By End User, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 151 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2026年血栓除去裝置市場規模估計為21億美元,預計2033年將達到35.3億美元。預計2026年至2033年,該市場將以7.7%的複合年成長率成長。

報告範圍 報告詳情
基準年: 2025 2026年市場規模: 21億美元
歷史數據時期: 2020年至2024年 預測期: 2026年至2033年
2026年至2033年預測期間的複合年成長率: 7.70% 2033年市場規模預測: 35.3億美元

在血栓切除術中,外科醫生使用機械血栓除去裝置(例如冠狀動脈內導管)來擊碎或清除血栓,從而恢復體內正常的血液流動。這使得神經外科醫師能夠改善患者的健康狀況,特別是那些患有主動脈中風的患者。由於卒中發病率高且醫療保健成本不斷上漲,血栓切除術在亞太地區的主要經濟體(例如中國、印度和澳洲)已廣泛應用。對於藥物治療(例如溶栓治療)可能無效或不適用的患者,例如近期接受過手術的患者或正在服用口服抗凝血劑的患者,可以使用血栓除去裝置。

市場動態

血栓除去裝置用於治療動脈、靜脈和微血管中的血栓。血栓除去裝置經過精心設計,旨在最大限度地減少血管壁損傷,並降低血栓切除術中的出血量。對微創血栓切除術日益成長的需求預計將推動全球血栓除去裝置市場的成長。例如,根據2021年美國心臟協會(AHA)日誌的報告,許多新冠肺炎患者出現心血管併發症,其中16.7%的患者出現心律不整,23%的患者出現心臟衰竭,這會增加急性缺血性腦中風的風險。在全球範圍內,5%至6%的重症新冠肺炎患者報告出現腦血管併發症。這促使人們更加關注如何改善中風患者獲得血管內治療(EVT)的機會,並縮短治療啟動時間,以改善中風患者的預後。

本次調查的主要特點

  • 本研究確定了各個細分市場的潛在商機,並為該市場說明了一個有吸引力的投資提案矩陣。
  • 此外,本研究還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要參與者採取的競爭策略的重要見解。
  • 本研究根據以下參數創建了全球血栓除去裝置市場主要公司的概況:公司概況、產品系列、主要亮點、財務表現和策略。
  • 透過利用本報告中的見解,企業行銷負責人和經營團隊將能夠就未來的產品發布、型號升級、市場擴張和行銷策略做出明智的決策。
  • 這份全球血栓除去裝置市場報告的目標受群眾外包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師等產業相關人員。
  • 相關人員可以透過利用全球血栓除去裝置市場分析中使用的各種策略矩陣來簡化決策過程。

目錄

第1章:研究目標與前提條件

  • 分析目的
  • 先決條件
  • 簡稱

第2章 市場展望

  • 報告說明
    • 市場定義和範圍
  • 執行摘要
  • Coherent Opportunity Map(COM)

第3章:市場動態、監管與趨勢分析

  • 市場動態
    • 促進因素
    • 抑制因子
    • 市場機遇
  • 影響分析
  • 近期產品核可上市
  • 併購和合作
  • 監管趨勢
  • 價格分析
  • 主要進展
  • PEST分析
  • 波特的分析

第4章 全球血栓除去裝置市場:依產品類型分類,2021-2033年

  • 機械血栓除去裝置
  • 抽吸式血栓除去裝置
  • 動態血栓除去裝置
  • 超音波血栓除去裝置

第5章 全球血栓除去裝置市場:依應用領域分類,2021-2033年

  • 深層靜脈栓塞症(DVT)
  • 肺動脈栓塞(PE)
  • 淺層靜脈血栓症
  • 腎靜脈血栓症(RVT)
  • 動脈血栓症(血栓症)
  • 其他(例如,缺血性中風)

第6章 全球血栓除去裝置市場:依最終用戶分類,2021-2033年

  • 醫院
  • 門診手術中心
  • 其他(學術和研究機構等)

第7章 全球血栓除去裝置市場:依地區分類,2021-2033年

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 義大利
    • 法國
    • 西班牙
    • 俄羅斯
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • ASEAN
    • 澳洲
    • 韓國
    • 其他亞太國家
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 其他拉丁美洲國家
  • 中東
    • GCC
    • 以色列
    • 其他中東國家
  • 非洲
    • 北非
    • 中非
    • 南非

第8章 競爭情勢

  • 公司簡介
    • Boston Scientific Corporation
    • Medtronic
    • Merit Medical System Inc.
    • Stryker Corporation
    • Terumo Corporation
    • Teleflex Incorporated
    • Vetex Medical Ltd.
    • Edwards Lifesciences Corporation
    • Penumbra Inc.
    • Control Medical Technology, LLC.
    • Rapid Medical
    • Abbott
    • Surmodics Inc.
    • Analysts'Views

第9章

  • 參考
  • 調查方法
簡介目錄
Product Code: CMI2254

Thrombectomy Devices Market is estimated to be valued at USD 2.10 Bn in 2026 and is expected to reach USD 3.53 Bn by 2033, growing at a compound annual growth rate (CAGR) of 7.7% from 2026 to 2033.

Report Coverage Report Details
Base Year: 2025 Market Size in 2026: USD 2.10 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2026 To 2033
Forecast Period 2026 to 2033 CAGR: 7.70% 2033 Value Projection: USD 3.53 Bn

Thrombectomy procedures allow surgeons to use a mechanical thrombectomy device such as intracoronary catheters to break up or remove the blood clot and restore normal blood flow in the human body. It helps neurosurgeons to improve patients' health, especially those experiencing a large artery stroke. Thrombectomy is widely used in major economies of Asia Pacific such as China, India, Australia, and others, due to high number of stroke incidences and increased spending in healthcare. Thrombectomy devices can be used in patients for whom pharmacological treatments such as thrombolysis are likely to be ineffective or inappropriate, for instance, in case of recent surgery or in patients who are taking oral anticoagulants.

Market Dynamics

Thrombectomy devices are used to treat blood clots present in the arteries, veins, and capillaries. Thrombectomy devices are carefully designed to minimize damage to the vessel wall during a blood clot removal procedure, with minimum blood loss. The rising demand for minimally invasive thrombectomy procedures is expected to drive the growth of the global thrombectomy devices market. For instance, as per a publication by the American Heart Association (AHA) Journals in 2021, patients with COVID-19 suffer from a number of cardiovascular complications, including 16.7% patients suffer from arrhythmia and 23% of patients suffer from heart failure, thus increasing risk for acute ischemic stroke. Cerebrovascular complications have been reported in 5% to 6% of patients with severe COVID-19, globally. This has increased concerns to improve the accessibility and shorten the time to endovascular therapy (EVT) for stroke to give patients better outcome after strokes.

Key features of the study

  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global thrombectomy devices market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study include LeMaitre Vascular, Inc., Boston Scientific Corporation, Control Medical Technology, Edwards Lifesciences Corporation, Johnson & Johnson, Medtronic Plc., Merit Medical Systems, Inc., Stryker Corporation, Terumo Corporation, Penumbra, Inc., Argon Medical Devices, Teleflex Incorporated, and Vetex Medical Ltd.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • The global thrombectomy devices market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global thrombectomy devices market.

Market Segmentation

  • By Product Type (Revenue, USD Bn, 2021 - 2033)
  • Mechanical Thrombectomy Devices
  • Aspiration Thrombectomy Devices
  • Hydrodynamic Thrombectomy Devices
  • Ultrasonic Thrombectomy Devices
  • By Application (Revenue, USD Bn, 2021 - 2033)
  • Deep Vein Thrombosis (DVT)
  • Pulmonary Embolism (PE)
  • Superficial Vein Thrombosis
  • Renal Vein Thrombosis (RVT)
  • Arterial Thrombosis (Atherothrombosis)
  • Others (Ischemic Stroke, etc.)
  • By End User (Revenue, USD Bn, 2021 - 2033)
  • Hospitals
  • Ambulatory Surgical Centers
  • Others (Academic and Research Institutes, etc)
  • By Region (Revenue, USD Bn, 2021 - 2033)
  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
  • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
  • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Key Players
  • Boston Scientific Corporation
  • Medtronic
  • Merit Medical System Inc.
  • Stryker Corporation
  • Terumo Corporation
  • Teleflex Incorporated
  • Vetex Medical Ltd.
  • Edwards Lifesciences Corporation
  • Penumbra Inc.
  • Control Medical Technology LLC.
  • Rapid Medical
  • Abbott
  • Surmodics, Inc.

Table of Contents

1. Research Objective and Assumption

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Product Type
    • Market Snippet, By Application
    • Market Snippet, By End User
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Recent Product Approvals/Launches
  • Mergers, Acquisitions, and Collaborations
  • Regulatory Scenario
  • Pricing Analysis
  • Key Developments
  • PEST Analysis
  • Porter's Analysis

4. Global Thrombectomy Devices Market, By Product Type, 2021- 2033, (USD Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Mechanical Thrombectomy Devices
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Segment Trends
  • Aspiration Thrombectomy Devices
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Segment Trends
  • Hydrodynamic Thrombectomy Devices
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Segment Trends
  • Ultrasonic Thrombectomy Devices
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Segment Trends

5. Global Thrombectomy Devices Market, By Application, 2021 - 2033, (USD Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Deep Vein Thrombosis (DVT)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Segment Trends
  • Pulmonary Embolism (PE)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Segment Trends
  • Superficial Vein Thrombosis
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Segment Trends
  • Renal Vein Thrombosis (RVT)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Segment Trends
  • Arterial Thrombosis (Atherothrombosis)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Segment Trends
  • Others (Ischemic Stroke, etc.)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Segment Trends

6. Global Thrombectomy Devices Market, By End User, 2021 - 2033, (USD Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Ambulatory Surgical Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Others (Academic and Research Institutes, etc.)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

7. Global Thrombectomy Devices Market, By Region, 2021 - 2033, (USD Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 -2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 -2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021-2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 -2033, (USD Bn)
      • U.S.
      • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 -2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 -2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021-2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 -2033, (USD Bn)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth. By Product Type, 2021 -2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 -2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021-2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 -2033, (USD Bn)
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 -2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 -2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth. By End User, 2021-2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 -2033, (USD Bn)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth By Product Type, 2021 -2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth By Application, 2021 -2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth By End User, 2021-2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth By Country, 2021 -2033, (USD Bn)
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 -2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 -2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021-2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 -2033, (USD Bn)
      • North Africa
      • Central Africa
      • South Africa

8. Competitive Landscape

  • Company Profiles
    • Boston Scientific Corporation
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • Medtronic
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • Merit Medical System Inc.
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • Stryker Corporation
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • Terumo Corporation
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • Teleflex Incorporated
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • Vetex Medical Ltd.
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • Edwards Lifesciences Corporation
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • Penumbra Inc.
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • Control Medical Technology, LLC.
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • Rapid Medical
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • Abbott
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • Surmodics Inc.
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • Analysts' Views

9. Section

  • References
  • Research Methodology
  • About us and Sales Contact